We have located links that may give you full text access.
Time Trends in Incidence and Mortality of Cutaneous Melanoma in Germany.
OBJECTIVES: To characterize incidence and mortality trends of cutaneous melanoma (CM) in Germany to extrapolate these data until 2030.
METHODS: We evaluated data from the Centre for Cancer Registry Data (1999-2012), and from the Saarland cancer registry (1970-2012). Age standardized (according to the European Standard Population, WHO 1976) incidence and mortality rates (ASIRs, ASMRs) and crude incidence and mortality rates (CIRs, CMRs) were analyzed.
RESULTS: In entire Germany, ASIRs increased by 55% to 19.2 and CIRs by 77% to 26.0 new cases per 100,000 from 1999-2012. ASMRs remained stable, whereas CMR increased by 58% to 4.1 for males, and by 30% to 3.0 for females per 100,000. In the Federal State of Saarland ASIRs increased more than 4 fold to 13.1, CIRs increased 6-7 fold to 18.5/100,000 from 1970-2012. In the same period, ASMRs increased 3 fold in males and 2 fold in females to 2.5 and 1.6, whereas CMRs increased 5.5 fold in males and 3.5 fold in females to 3.9 and 3.2/100,000, mainly caused by steep increases of CIRs and CMRs in age groups ≥60 years. Projected CIRs will rise to 44-46 for males and 38-40 for females in 2030. Steepest increases were extrapolated for patients ≥60 years, especially for males, but are also expected for age groups of 40-59 years. In contrast CIRs are anticipated to stabilize for subjects <40 years.
CONCLUSIONS: There is a constant increase of incidence and mortality rates for CM in Germany. As the German population is ageing and the current population has already accumulated high levels of UV exposure, a further increase in melanoma incidence, is projected for the future without signs of leveling-off. This article is protected by copyright. All rights reserved.
METHODS: We evaluated data from the Centre for Cancer Registry Data (1999-2012), and from the Saarland cancer registry (1970-2012). Age standardized (according to the European Standard Population, WHO 1976) incidence and mortality rates (ASIRs, ASMRs) and crude incidence and mortality rates (CIRs, CMRs) were analyzed.
RESULTS: In entire Germany, ASIRs increased by 55% to 19.2 and CIRs by 77% to 26.0 new cases per 100,000 from 1999-2012. ASMRs remained stable, whereas CMR increased by 58% to 4.1 for males, and by 30% to 3.0 for females per 100,000. In the Federal State of Saarland ASIRs increased more than 4 fold to 13.1, CIRs increased 6-7 fold to 18.5/100,000 from 1970-2012. In the same period, ASMRs increased 3 fold in males and 2 fold in females to 2.5 and 1.6, whereas CMRs increased 5.5 fold in males and 3.5 fold in females to 3.9 and 3.2/100,000, mainly caused by steep increases of CIRs and CMRs in age groups ≥60 years. Projected CIRs will rise to 44-46 for males and 38-40 for females in 2030. Steepest increases were extrapolated for patients ≥60 years, especially for males, but are also expected for age groups of 40-59 years. In contrast CIRs are anticipated to stabilize for subjects <40 years.
CONCLUSIONS: There is a constant increase of incidence and mortality rates for CM in Germany. As the German population is ageing and the current population has already accumulated high levels of UV exposure, a further increase in melanoma incidence, is projected for the future without signs of leveling-off. This article is protected by copyright. All rights reserved.
Full text links
Related Resources
Trending Papers
Challenges in Septic Shock: From New Hemodynamics to Blood Purification Therapies.Journal of Personalized Medicine 2024 Februrary 4
Molecular Targets of Novel Therapeutics for Diabetic Kidney Disease: A New Era of Nephroprotection.International Journal of Molecular Sciences 2024 April 4
The 'Ten Commandments' for the 2023 European Society of Cardiology guidelines for the management of endocarditis.European Heart Journal 2024 April 18
A Guide to the Use of Vasopressors and Inotropes for Patients in Shock.Journal of Intensive Care Medicine 2024 April 14
Diagnosis and Management of Cardiac Sarcoidosis: A Scientific Statement From the American Heart Association.Circulation 2024 April 19
Essential thrombocythaemia: A contemporary approach with new drugs on the horizon.British Journal of Haematology 2024 April 9
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app